Loading...

Home
ETF
LCTX

LCTX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LCTX News

Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion

Jan 29 2026Newsfilter

Avant Technologies Drives 67.5% Market Share in Cell Therapy Manufacturing

Dec 16 2025Newsfilter

Snowflake, Symbotic, and Other Major Stocks Decline in Thursday's Pre-Market Trading

Dec 04 2025Benzinga

Lineage Cell Therapeutics, Inc. (LCTX) Shares Prepared Remarks at H.C. Wainwright's 27th Annual Global Investment Conference

Sep 13 2025Newsfilter

Lineage Partners with William Demant Invest to Advance ReSonance™ (ANP1) for Hearing Loss Research

Aug 26 2025Newsfilter

Lineage Cell Revenue Doubles in Q2

Aug 13 2025NASDAQ.COM

Lineage signals expanded diversification strategy following OpRegen milestones and $42.3M cash position

Aug 12 2025SeekingAlpha

Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates

Aug 06 2025NASDAQ.COM

D. Boral Capital Maintains Buy on Lineage Cell Therapeutics, Maintains $2 Price Target

Aug 05 2025Benzinga

Two Biotech Stocks Poised For Big Moves On Monday

Jun 23 2025Benzinga

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025

Jun 23 2025Newsfilter

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

May 14 2025Newsfilter

Lineage Cell Therapeutics outlines manufacturing milestone and anticipates OpRegen 36-month data update while advancing OPC1 clinical plans

May 13 2025SeekingAlpha

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

May 12 2025NASDAQ.COM

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025

May 12 2025Newsfilter

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)

Apr 21 2025Newsfilter